Stefan Koehrer

418 total citations
14 papers, 287 citations indexed

About

Stefan Koehrer is a scholar working on Genetics, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Stefan Koehrer has authored 14 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 7 papers in Pathology and Forensic Medicine and 6 papers in Molecular Biology. Recurrent topics in Stefan Koehrer's work include Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (6 papers) and Acute Lymphoblastic Leukemia research (5 papers). Stefan Koehrer is often cited by papers focused on Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (6 papers) and Acute Lymphoblastic Leukemia research (5 papers). Stefan Koehrer collaborates with scholars based in United States, Austria and Germany. Stefan Koehrer's co-authors include Jan A. Burger, Volker Wacheck, Daniel Cejka, Thorsten Fuereder, Sabine Strommer, R. Eric Davis, Ekaterina Kim, Eva Zebedin, Zhiqiang Wang and Johannes Werzowa and has published in prestigious journals such as Blood, Clinical Cancer Research and Journal of Investigative Dermatology.

In The Last Decade

Stefan Koehrer

13 papers receiving 285 citations

Peers

Stefan Koehrer

GENET

ONCOL

PFM

IMMUN

Thomas Mehrling United Kingdom

Pasquale L. Fedele Australia

Mutiah Apatira United States

F Davi France

Josephine L. Klitgaard United States

Kris Jacobs Belgium

Dieuwertje M. Luijks Netherlands

Sandeep Potluri United Kingdom

Kenneth Anderson United States

Julia Romani Germany

Thomas Mehrling United Kingdom

Stefan Koehrer

132 ×1.1

73 ×0.7

GENET

81 ×1.0

ONCOL

70 ×1.0

PFM

33 ×0.5

IMMUN

Citations per year, relative to Stefan Koehrer Stefan Koehrer (= 1×) peers Thomas Mehrling

Countries citing papers authored by Stefan Koehrer

Since Specialization

Citations

This map shows the geographic impact of Stefan Koehrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Koehrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Koehrer more than expected).

Fields of papers citing papers by Stefan Koehrer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Koehrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Koehrer. The network helps show where Stefan Koehrer may publish in the future.

Co-authorship network of co-authors of Stefan Koehrer

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Koehrer. A scholar is included among the top collaborators of Stefan Koehrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Koehrer. Stefan Koehrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Koehrer, Stefan & Jan A. Burger. (2023). Chronic Lymphocytic Leukemia: Disease Biology. Acta Haematologica. 147(1). 8–21. 12 indexed citations

Nebral, Karin, et al.. (2023). Nanopore Cas9-Targeted Long-Read Sequencing - a Fast and Flexible Diagnostic Tool for the Identification of B-Cell Acute Lymphoblastic Leukemia Associated Gene Rearrangements. Blood. 142(Supplement 1). 2984–2984.

Blunt, Matthew D., Stefan Koehrer, Rachel Dobson, et al.. (2016). The Dual Syk/JAK Inhibitor Cerdulatinib Antagonizes B-cell Receptor and Microenvironmental Signaling in Chronic Lymphocytic Leukemia. Clinical Cancer Research. 23(9). 2313–2324. 54 indexed citations

Koehrer, Stefan & Jan A. Burger. (2016). B-cell receptor signaling in chronic lymphocytic leukemia and other B-cell malignancies.. PubMed. 14(1). 55–65. 24 indexed citations

Kim, Ekaterina, Christian Hurtz, Stefan Koehrer, et al.. (2016). Ibrutinib inhibits pre-BCR+ B-cell acute lymphoblastic leukemia progression by targeting BTK and BLK. Blood. 129(9). 1155–1165. 58 indexed citations

Ghosh, Dipanjan, Mariela Sivina, Stefan Koehrer, et al.. (2016). Effects of pharmacological and genetic disruption of CXCR4 chemokine receptor function in B‐cell acute lymphoblastic leukaemia. British Journal of Haematology. 174(3). 425–436. 29 indexed citations

Havránek, Ondřej, Stefan Koehrer, Zhiqiang Wang, et al.. (2014). The B-Cell Receptor Is Required for Optimal Viability, Growth, and Chemotherapy Resistance of Diffuse Large B-Cell Lymphoma Cell Lines of the Germinal Center B-Cell Subtype. Blood. 124(21). 493–493. 3 indexed citations

Kim, Ekaterina, Stefan Koehrer, Nathalie Y. Rosin, et al.. (2013). Bruton′s Tyrosine Kinase Inhibitor Ibrutinib Interferes With Constitutive and Induced Pre-B Cell Receptor Signaling In B-Cell Acute Lymphoblastic Leukemia. Blood. 122(21). 1399–1399. 1 indexed citations

Rosin, Nathalie Y., Ekaterina Kim, Stefan Koehrer, et al.. (2013). The PI3K Delta Inhibitor Idelalisib Interferes With Pre-B Cell Receptor Signaling In Acute Lymphoblastic Leukemia (ALL): A New Therapeutic Concept. Blood. 122(21). 2632–2632. 3 indexed citations

10.

Kim, Ekaterina, Stefan Koehrer, Nathalie Y. Rosin, et al.. (2012). Activity of Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib (PCI-32765) in B-Cell Acute Lymphoblastic Leukemia (B-ALL).. Blood. 120(21). 2569–2569. 10 indexed citations

11.

Rosin, Nathalie Y., Stefan Koehrer, Ekaterina Kim, et al.. (2012). In Vitro Effects of PI3Kδ Inhibitor GS-1101 (Cal-101) in Acute Lymphoblastic Leukemia (ALL). Blood. 120(21). 3534–3534. 3 indexed citations

12.

Cejka, Daniel, Ying Liu, Matthias Preusser, et al.. (2010). Effects of vatalanib on tumor growth can be potentiated by mTOR blockade in vivo. Cancer Biology & Therapy. 9(11). 919–927. 8 indexed citations

13.

Fuereder, Thorsten, Doris Hoeflmayer, Matthias Preusser, et al.. (2010). mTOR inhibition by everolimus counteracts VEGF induction by sunitinib and improves anti-tumor activity against gastric cancer in vivo. Cancer Letters. 296(2). 249–256. 36 indexed citations

14.

Werzowa, Johannes, Stefan Koehrer, Sabine Strommer, et al.. (2010). Vertical Inhibition of the mTORC1/mTORC2/PI3K Pathway Shows Synergistic Effects against Melanoma In Vitro and In Vivo. Journal of Investigative Dermatology. 131(2). 495–503. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact